The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice
The information contained in this publication is intended for educational purposes only and should not be considered clinical, financial, or legal advice
Compounded GLP-1 medications are not FDA-approved
GLP-1 receptor agonists are subject to stringent regulatory requirements that restrain market expansion by increasing development timelines and approval costs
Like many providers who prescribe GLP-1s, Yuval Pinto, MD, has worked with select patients to gradually reduce how often they take the medication
About this article Cite this article Karacabeyli, D., Lacaille, D